DIFFERENCES OF 2 BORRELIA-BURGDORFERI STRAINS IN COMPLEMENT ACTIVATION AND SERUM RESISTANCE

被引:52
作者
BRADE, V
KLEBER, I
ACKER, G
机构
[1] UNIV ERLANGEN NURNBERG, INST CLIN MICROBIOL, W-8520 ERLANGEN, GERMANY
[2] UNIV BAYREUTH, DEPT ELECTRON MICROSCOPY, W-8580 BAYREUTH, GERMANY
关键词
D O I
10.1016/S0171-2985(11)80087-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Complement activation and serum resistance of the Borrelia burgdorferi strains B31 (American strain) and PKo (European strain) were compared. In 25 % (v/v) normal human serum (NHS) free of B. burgdorferi-specific antibodies the cells of the PKo strain were high activators of complement as indicated by rapid and strong C9 consumption, by deposition of up to 336763 C9 molecules per cell and by the formation of the terminal complement complex on the cell surface. By comparison, complement activation by the B31 strain was low with 5.4-fold less C9 deposited per cell. The addition of B. burgdorferi-specific antibodies to NHS either as purified IgG or heat-inactivated patient sera, had no influence on the results with both strains. After an incubation period of 2 h at 37-degrees-C in 25 % (v/v) NHS most cells of the PKo strain had lost their viability as indicated by cell immobilization and failure to multiply in subcultures. In addition, extensive cell fragmentation and bleb formation were observed in the electron microscope. In contrast, the B31 strain remained alive and morphologically intact after the same incubation with NHS. We conclude from our results that complement activation and serum resistance are properties which differ considerably between isolated strains of B. burgdorferi.
引用
收藏
页码:453 / 465
页数:13
相关论文
共 23 条
[1]   PHENOTYPIC AND GENOTYPIC ANALYSIS OF BORRELIA-BURGDORFERI ISOLATES FROM VARIOUS SOURCES [J].
ADAM, T ;
GASSMANN, GS ;
RASIAH, C ;
GOBEL, UB .
INFECTION AND IMMUNITY, 1991, 59 (08) :2579-2585
[2]  
ASBRINK E, 1985, ACTA PATH MICRO IM B, V93, P161
[3]   BIOLOGY OF BORRELIA SPECIES [J].
BARBOUR, AG ;
HAYES, SF .
MICROBIOLOGICAL REVIEWS, 1986, 50 (04) :381-400
[4]   PLASMID ANALYSIS OF BORRELIA-BURGDORFERI, THE LYME-DISEASE AGENT [J].
BARBOUR, AG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (03) :475-478
[5]  
BIESECKER G, 1980, J IMMUNOL, V124, P1291
[6]   LYME-DISEASE ASSAY WHICH DETECTS KILLED BORRELIA-BURGDORFERI [J].
CALLISTER, SM ;
SCHELL, RF ;
LOVRICH, SD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (09) :1773-1776
[7]   METHODS FOR INCREASING THE RESOLUTION OF TWO-DIMENSIONAL PROTEIN ELECTROPHORESIS [J].
HOCHSTRASSER, DF ;
HARRINGTON, MG ;
HOCHSTRASSER, AC ;
MILLER, MJ ;
MERRIL, CR .
ANALYTICAL BIOCHEMISTRY, 1988, 173 (02) :424-435
[8]   STUDIES ON THE MECHANISM OF BACTERIAL-RESISTANCE TO COMPLEMENT-MEDIATED KILLING .1. TERMINAL COMPLEMENT COMPONENTS ARE DEPOSITED AND RELEASED FROM SALMONELLA-MINNESOTA S218 WITHOUT CAUSING BACTERIAL DEATH [J].
JOINER, KA ;
HAMMER, CH ;
BROWN, EJ ;
COLE, RJ ;
FRANK, MM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (03) :797-808
[9]   ROLE OF IMMUNOGLOBULIN-G IN KILLING OF BORRELIA-BURGDORFERI BY THE CLASSICAL COMPLEMENT PATHWAY [J].
KOCHI, SK ;
JOHNSON, RC .
INFECTION AND IMMUNITY, 1988, 56 (02) :314-321
[10]  
KOCHI SK, 1991, J IMMUNOL, V146, P3964